TRRI — Alzex Neuropharma Balance Sheet
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.15m
- $0.22m
Annual balance sheet for Alzex Neuropharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PRESS | PRESS |
| Standards: | — | — |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 0 | 0.001 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 0.002 | 0 |
| Total Current Assets | 0.002 | 0.001 |
| Net Property, Plant And Equipment | 0 | 0.032 |
| Other Long Term Assets | ||
| Total Assets | 0.084 | 0.033 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 0.072 | 0.054 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | 0.157 | 0.134 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | -0.072 | -0.102 |
| Total Liabilities & Shareholders' Equity | 0.084 | 0.033 |
| Total Common Shares Outstanding |